white-border-top

ABOUT US

we are passionate in our commitment to save and improve the lives of patients.

We are a late-stage company developing fusion protein medicines. Our fusion protein approach tethers a tumor-targeting antibody fragment to a protein cytotoxic payload to form a single protein molecule designed to selectively and broadly kill cancer cells while minimizing toxicity to healthy cells and to activate the body’s innate immune response system.

executive leadership team

Thomas Cannell, DVM

President & Chief Executive Officer

Glen MacDonald, Ph.D.

Chief Technology Officer

Mark R. Sullivan

General Counsel and Corporate Secretary

Monica Forbes

Chief Financial Officer

Erin Clark

Vice President, Corporate Strategy and Investor Relations

Omar Rifi

Vice President, Business Development and Alliance Management

Louise Stejbach

Commercial Advisor

Jeannick Cizeau

Head of Research

board of directors

Wendy L. Dixon, Ph.D.

Chairwoman of the Board of Directors

Thomas Cannell, DVM

President & Chief Executive Officer

Jay S. Duker, M.D.

Director

Jane V. Henderson

Director

Daniel S. Lynch

Director

ceo medical advisory board

Rian Dickstein, MD, FACS

Chief of Urology - University of Maryland Baltimore Washington Medical Center

Michael A.S. Jewett, MD, FRCSC, FACS

Professor, Departments of Surgical Oncology and Surgery (Urology), Princess Margaret Cancer Centre, University Health Network and the University of Toronto

Wassim Kassouf, MD, CM, FRCSC

Professor and Associate Chair Dept. of Surgery - McGill University

Thomas Keane, MD

Medical University of South Carolina (Charleston) – Professor and Chair Department of Urology

Donald Lamm, MD

Clinical Professor, University of Arizona

Michael O’Donnell, MD

Richard D Williams Professor and Director of Urologic Oncology University of Iowa Carver College of Medicine

Neal D. Shore, MD, FACS

Director, CPI, Carolina Urologic Research Center Atlantic Urology Clinics Myrtle Beach, South Carolina

Alon Weizer, MD

Professor of Urology – University of Michigan

Fred N. Wolk, MD, FACS

Director of Clinical Trials, Skyline Urology Torrance, CA

IMPROVE LIFE

change lives with us

We are a group of motivated individuals who are committed to changing lives for the better. Learn more about our open positions and how you can improve life with us.

Learn More
Top